OpenVSafe by OpenVAERS
Search V-safe

NWJ-33854-94768

3 vaccinations 1 coded response 14 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
809 / CO
Registered
2020-12-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-20
    Registered in v-safe
  3. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Joint pains
    Adult check-in
  4. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  5. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  6. 2020-12-25
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-08
    Dose 2 — Pfizer-BioNTech
  8. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-01-09
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-01-10
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  12. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  13. 2021-10-12
    Dose 3 — Pfizer-BioNTech
  14. 2021-10-12
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  15. 2021-10-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  16. 2021-10-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Itching · Nausea, Abdominal pain
    Adult check-in
  17. 2021-10-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  18. 2021-10-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  19. 2021-10-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  20. 2021-10-18
    Survey response — days 1–6 daily, dose 3
    MedDRA: Insomnia, Rhinorrhoea, Upper-airway cough syndrome — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school
    Free text: Runny nose, insomnia m, post nasal drip
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-08Pfizer-BioNTech
32021-10-12Pfizer-BioNTech No

Call center

2 call center cases

2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-18

Systemic reaction (other): Runny nose, insomnia m, post nasal drip

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROInsomnia · · ✓
SRORhinorrhoea · · ✓
SROUpper-airway cough syndrome · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release